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The strength of synaptic inhibition can be controlled by the stability and endocytosis of surface and synaptic GABAA receptors
(GABAARs), but the surface receptor dynamics that underpin GABAAR recruitment to dendritic endocytic zones (EZs) have not been
investigated. Stabilization of GABAARs at EZs is likely to be regulated by receptor interactions with the clathrin-adaptor AP2, but the
molecular determinants of these associations remain poorly understood.Moreover, although surface GABAAR downmodulation plays a
key role in pathological disinhibition in conditions such as ischemia and epilepsy, whether this occurs in anAP2-dependentmanner also
remains unclear. Herewe report the characterization of a novelmotif containing three arginine residues (405RRR407) within the GABAAR
3-subunit intracellular domain (ICD), responsible for the interaction with AP2 and GABAAR internalization. When this motif is dis-
rupted, binding to AP2 is abolished in vitro and in rat brain. Using single-particle tracking, we reveal that surface3-subunit-containing
GABAARs exhibit highly confinedbehavior at EZs,which is dependent onAP2 interactions via thismotif. Reduced stabilizationofmutant
GABAARs at EZs correlates with their reduced endocytosis and increased steady-state levels at synapses. By imagingwild-type ormutant
super-ecliptic pHluorin-tagged GABAARs in neurons, we also show that, under conditions of oxygen–glucose deprivation to mimic
cerebral ischemia, GABAARs are depleted from synapses in dendrites, depending on the
405RRR407 motif. Thus, AP2 binding to an RRR
motif in the GABAAR 3-subunit ICD regulates GABAAR residency time at EZs, steady-state synaptic receptor levels, and pathological
loss of GABAARs from synapses during simulated ischemia.
Introduction
GABAA receptors (GABAARs) are the mainmediators of inhibitory
neurotransmission in the CNS and play an essential role in main-
taining the excitatory/inhibitory balance required for correct brain
function (Smith and Kittler, 2010). Modulating the abundance of
GABAARs at synaptic sites is a key mechanism for determining the
strength of synaptic inhibition (Arancibia-Ca´rcamo and Kittler,
2009).However, the exactmolecularprocesses thatunderlie changes
in GABAAR numbers at synapses and hence synaptic efficacy under
normal or pathological conditions remain poorly understood.
GABAARs are dynamic entities, in terms of both their lateral
mobility at the plasmamembrane (Bannai et al., 2009;Muir et al.,
2010) and their trafficking to and from the cell surface (Smith and
Kittler, 2010). Clathrin-mediated endocytosis of GABAARs is de-
pendent on the clathrin-adaptor AP2 and rapidlymodulates syn-
aptic GABAAR number, inhibitory synaptic strength, neuronal
excitability, and, ultimately, animal behavior (Kittler et al., 2000,
2005; Chen et al., 2006; Kurotani et al., 2008; Tretter et al., 2009).
Although a number of recent studies have investigated the diffu-
sion ofGABAARs into and out of synapses, far less is known about
GABAARmembrane dynamics at endocytic zones (EZs) and how
GABAARs are recruited to and stabilized at these regions.
Disrupted GABAAR trafficking contributes to altered infor-
mation processing in pathological conditions such as epilepsy
and ischemia, in which acute receptor surface downmodulation
and loss of synaptic GABAARs leads to compromised neuronal
inhibition and altered excitability states, but the underlying
mechanisms remain unclear (Mielke and Wang, 2005; Naylor et
al., 2005; Tan et al., 2007; Arancibia-Ca´rcamo et al., 2009). In-
deed, although both clathrin-dependent and -independent (e.g.,
caveolar-dependent) pathways for GABAAR endocytosis have
been described (Kittler et al., 2000; Bradley et al., 2008), the spe-
cific contribution of AP2-dependent pathways for synaptic re-
ceptor loss in epilepsy or ischemia remains unclear. Deciphering
the molecular mechanisms and endocytic pathways responsible
for synaptic GABAAR downmodulation is therefore central to
understanding how synaptic inhibition is regulated in the healthy
brain and could lead to identification of potential target pathways
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of pathological receptor downmodulation for therapeutic inter-
vention during disinhibition in disease.
Here, we characterize themolecular interactions that underlie
internalization of GABAARs containing 3 subunits, which are
present in a large proportion of receptor subtypes in the hip-
pocampus and cortex, regions that are particularly vulnerable to
excitotoxicity (Lo et al., 2003). Using a combination of molecu-
lar, biochemical, and imaging approaches, we identify a three
arginine (RRR)motif within the GABAAR3-subunit intracellu-
lar domain (ICD) that mediates the clathrin-dependent endocy-
tosis of GABAARs via direct binding to AP2. Furthermore, by
combining single-particle tracking with mutagenesis of the RRR
motif, we reveal that GABAARs are reversibly stabilized at EZs,
depending on interactions with AP2. Additionally, we demon-
strate that loss of synaptic GABAARs in an in vitromodel of isch-
emia is dependent on AP2-binding via this motif and that
blocking this mechanism can reduce cell death. Thus, direct
binding of GABAAR ICDs to AP2 regulates GABAAR recruitment
into EZs, steady-state GABAAR levels at synapses, and provides a
key mechanism for receptor downmodulation in pathology.
Materials andMethods
cDNA cloning. The 3 GABAAR-subunit mutants were made by site-
directed mutagenesis on a pRK5myc3 backbone. The ICDs of these
mutants were amplified by PCR, and the resulting fragment was inserted
into the BamH1/Not1 sites of pGEX–4T3. SEP2 (Superecliptic pHluo-
rin) has been described previously (Muir et al., 2010). Untagged 1 was
in pRK5 and was described previously (Twelvetrees et al., 2010). mRFP–
rab5 [Addgene plasmid 14437 (Vonderheit and Helenius, 2005)] and
clathrin-light chain polypeptide–EYFP [Addgene plasmid 21741 (Chen
and Zhuang, 2008)] were from Addgene. EGFP was from Clontech.
Antibodies.The followingprimaryantibodieswereused:mousemonoclo-
nal anti-Myc was obtained from 9E10 hybridoma cells [immunofluores-
cence (IF) and ELISA, supernatant 1:100], anti-AP50 [Western blot (WB),
1:250;BDBiosciences], anti-GFP(IF, 1:500; cloneN86/38;Neuromab), rab-
bit polyclonal anti-myc [IF, 1:200; quantumdot (QD) imaging, 1:100; Santa
Cruz Biotechnology], rabbit anti-vesicular inhibitory amino acid trans-
porter (VIAAT) [a kind gift from B. Gasnier, Universite Paris, Descartes,
France (Dumoulin et al., 1999); IF, 1:1000], anti-1GABAAR subunit (WB,
1:5; clone N95/35; Neuromab), anti--adaptin (WB, 1:500; Sigma), vesicu-
lar GABA transporter (VGAT)–Oyster 488 (live imaging, 1:1000; Synaptic
Systems), and anti-myc (QD imaging, 1:100;Millipore Bioscience Research
Reagents).
Cell culture. Cultures of cortical and hippocampal neurons were pre-
pared from E18 Sprague Dawley rat embryos of either sex as described
previously (Kittler et al., 2004). Neurons were transfected by nucleofec-
tion before plating as described previously (Kittler et al., 2004; Macaskill
et al., 2009; Twelvetrees et al., 2010). COS-7 cells were maintained in
DMEM (Invitrogen), supplemented with 10% heat-inactivated fetal bo-
vine serum and penicillin–streptomycin, and transfected by electropora-
tion (Kittler et al., 2004) for biochemistry and by nucleofection (Amaxa)
for immunocytochemistry.
GST fusion protein pull-down assays from rat brain homogenate. Pull-
downs from brain were performed as described previously (Smith et al.,
2008, 2010). Briefly, adult rat brain was homogenized in pull-down buf-
fer (50 mM HEPES, pH 7.5, 0.5% Triton X-100, 150 mM NaCl, 1 mM
EDTA, and 1 mM PMSF with antipain, pepstatin, and leupeptin at 10
g/ml) and solubilized for 2 h. Solubilized material was ultracentrifuged
at 66,000 g for 40min at 4°C, and the supernatant (solubilized protein)
was exposed to 10–20g of GST fusion protein attached to glutathione–
agarose beads for 1 h at 4°C. Beads were then washed extensively and
analyzed by SDS-PAGE and WB.
In vitro translation of [ 35S]methionine-labeled protein and GST pull-
down assays. Residues 156–433 of the 2 subunit of AP2 were in vitro
translated usingTNTSP6QuickCoupledTranscription/Translation sys-
tem (Promega) and labeled with [ 35S]methionine (GE Healthcare) fol-
lowing the protocol of the manufacturer (Smith et al., 2008, 2010). Five
microliters of labeled protein were incubated with 10–20 g of GST
fusion protein in pull-down buffer (as above) for 2 h at 4°C. The beads
were washed and resolved by SDS-PAGE followed by staining with Coo-
massie blue. Radioactivity was detected with a phosphor-storage screen
and PhosphorImager. Bacterially expressed wild-type (WT) or mutant
(mut) His-tagged 2 were used for nonradioactive in vitro pull-downs
with GST fusion proteins and analyzed by SDS-PAGE, followed by stain-
ing with Coomassie blue (Smith et al., 2008).
Surface plasmon resonance. Surface plasmon resonance (SPR) experi-
ments were performed as described previously (Kittler et al., 2008) on a
BIAcore 2000 instrument (BIAcore).
Immunofluorescence. For receptor internalization assays in COS-7
cells, receptors were live labeled with 9E10 anti-myc antibody in HEPES
buffer (in mM: 25 HEPES, 140 NaCl, 5.4 KCl, 1.8 CaCl2, and 15 glucose,
pH 7.4) at 4°C. Labeled receptors were allowed to internalize for 30 min
at 37°C, and surface antibody was stripped away using 0.2 M acetic acid
and 0.5 M NaCl before fixation as described previously (Arancibia-
Ca´rcamo et al., 2009). Internalized receptors were identified using Alexa
Fluor-594-conjugated or Alexa Fluor-488-conjugated anti-mouse sec-
ondary antibody (1:1000; Invitrogen) and confocal microscopy. Quanti-
fication of receptor internalization was performed by determining the
area of the internalized receptors and normalization to the cell area (as
given by GFP fluorescence; described by Hanley and Henley, 2005) or by
measuring the colocalization of the internalized receptors with the early
endosomal marker rab5.
Receptor internalization assays in neurons were performed similarly
to what has been described previously (Scott et al., 2004), with modifi-
cations. Briefly, transfected neurons were incubated at room tempera-
ture with anti-9E10 antibody and placed at 37°C for 30 min to enable
internalization. After washing, cells were fixed and surface receptors were
stained with secondary Alexa Fluor-488 secondary antibody. Cells were
permeabilized and stained with Alexa Fluor-594 secondary antibody to
label the total receptor population and then visualized by confocal mi-
croscopy. For quantification of receptor internalization, red fluorescence
that was not colocalized with green fluorescence (surface receptors) was
calculated as the internalized receptor population and normalized to
total receptor population.
Neurons for surface staining were fixed with 4% paraformaldehyde
(PFA)/4% sucrose/PBS, pH 7, for 4 min and blocked with block solution
(PBS, 10% horse serum, and 0.5% BSA) for 10 min. Neurons were incu-
bated for 1 h with anti-9E10, followed by permeabilization with block
solution containing 0.2% Triton X-100. Neurons were then incubated
with anti-VIAAT antibody and subsequently with Alexa Fluor-488 and
Alexa Fluor-594 secondary antibodies (1:1000; Invitrogen). After exten-
sive washing, coverslips were mounted on microscope slides using Pro-
Long Gold antifade reagent (Invitrogen) and sealed with nail varnish.
Images were acquired using a Carl Zeiss Pascal confocal microscope and
digitally captured using LSM software.
Surface receptor ELISA assay. Quantification of surface myc-tagged
GABAARs was performed by colorimetric cell ELISA as described previ-
ously (Mielke and Wang, 2005). Briefly, 8–9 DIV cultured cortical neu-
rons were fixed with 4% PFA/sucrose for 5 min and then blocked under
nonpermeabilizing conditions (PBS and 3%BSA). Cells were incubated
for 1 h with anti-9E10 (1:100) and then for 1 h with HRP-conjugated
anti-mouse secondary antibody (1:2000; Rockland). After extensive
washing, cells were incubated with 1 vol of o-phenylenediamine sub-
strate (Sigma) for 3 min. Reactions were stopped using 0.2 vol of 3N
HCl, and 1 ml of supernatant was used to determine the absorbance at
492 nm. For N-ethylmaleimide-sensitive factor (NSF) inhibition exper-
iments, COS-7 cells expressing myc-tagged GABAARs were incubated
with a TAT-fused NSF inhibitory peptide (NSFi) or scrambled control
peptide for 75 min (Anachem) (Morrell et al., 2005; Chou et al., 2010),
followed by the ELISA procedure described above.
Live-cell imaging and oxygen–glucose deprivation. Hippocampal neu-
rons were nucleofected at time of plating with myc3 (WT, RRR/AAA or
7A), SEP2, and untagged 1 in a ratio of 2:1:1. To assess the cotransfec-
tion of myc3WT, myc3RRR/AAA, and myc37A with the SEP2 in hip-
pocampal neurons, neurons were live labeled for 15 min with a mouse
anti-GFP antibody diluted in HEPES buffer (in mM: 25 HEPES, 140
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NaCl, 5.4 KCl, 1.8 CaCl2, and 15 glucose, pH 7.4) to label
SEP2
clusters. Cells were then fixed and blocked as described above and
labeled with rabbit anti-myc antibody to label myc3-subunit-
containing receptors. Coverslips were washed and mounted as de-
scribed above. Quantification of cotransfection was performed by
assessing whether the SEP2-transfected neurons in a 40 field of
view were also expressing myc3 subunits. This was then expressed as
a percentage of the SEP2-transfected neurons.
Cells were imaged at 12–15 DIV as described previously (Arancibia-
Ca´rcamo et al., 2009). Carbonate-buffered solution contained 126 mM
NaCl, 2.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 1 mM NaH2PO4, 24 mM
NaHCO3, and 10mM glucose and was gassed with 95%O2, 5% CO2. For
oxygen–glucose deprivation (OGD), 7 mM sucrose was used in place of
glucose, and the solution was gassed with 95% N2, 5% CO2. Both solu-
tions were bubbled for 30 min before addition of CaCl2 to prevent pre-
cipitate formation. Solutions were perfused at a constant rate of 2
ml/min and heated to 35–37°C. For OGD experiments, the solution was
switched from control toOGDbuffer at t 0min. Super-ecliptic pHluo-
rin fluorescence was captured using an Olympus microscope (BX51WI)
with a 60 Olympus objective coupled to an EM-CCD camera (Ixon;
Andor). Excitation was provided by a mercury-spiked xenon arc lamp
(Cairn). Bandpass filters for excitation and emission were used (470/40
and 525/50 nm, respectively). Images (averages of eight consecutive ex-
posures of 150 ms) were acquired every 10 min. The StackReg macro
(The´venaz et al., 1998) was used to correct for minor x–y drift that may
have occurred between time points. Using NIH ImageJ, regions of inter-
est were drawn around each non-somatic fluorescent cluster. After back-
ground subtraction, the average intensity across SEP-GABAAR clusters
in each time point was used as readout. This value was normalized to that
at t 0 min.
For cell death assays, hippocampal cultures were transduced with pep-
tides (3 peptide, KTHLRRRSSQLK; control peptide, INRVDAHE-
NAAAAPM) for 1 h using Chariot reagent (active motif) following the
instructions of the manufacturer (Kittler et al., 2008; Twelvetrees et al.,
2010). After peptide transduction, cultures were exposed to 40minOGD
using a Billups-Rothenberg modular incubator chamber as described
previously (Dixon et al., 2009) using the control and OGD buffers de-
scribed above. Tomonitor cell death, 24 h after OGD treatment, neurons
were stained with propidium iodide (PI) (4 g/ml) for 1 h, followed by
fixation with 4% PFA/sucrose and staining with DAPI. For each experi-
ment, six to eight fields of view were imaged per condition, and the
number of DAPI-positive nuclei that were PI stained was determined.
Single-particle tracking. Labeling of myc-tagged GABAARs (
myc3WT
and myc3RRR/AAA) with QDs was performed using a rabbit anti-myc
antibody (Santa Cruz Biotechnology) ormouse anti-myc antibody (Mil-
lipore Bioscience Research Reagents) and anti-rabbit or anti-mouse 605
nm QDs (Invitrogen). Labeling was performed at room temperature
with primary antibody (0.1 g/ml, 1:100) for 8 min in block solution
(imaging media containing 10% horse serum) and then QD incubation
(0.5 nM) for 2 min in block solution as above. QDmovies were recorded
for 200 frames at 8.5 Hz (23.5 s duration). The imaging media for these
experiments contained the following (inmM): 125 NaCl, 5 KCl, 1MgCl2,
2 CaCl2, 10 D-glucose, and 10 HEPES, adjusted to pH 7.4. Labeling of
inhibitory presynaptic terminals with VGAT–Oyster 488 (1:1000; Syn-
aptic Systems) was performed by incubation of coverslips in 200 l of
imaging media for 30 min at 37°C, 5% CO2, and we found that sponta-
neous activity in the neuronal culture was sufficient to load the dye into
inhibitory presynaptic terminals. Similar staining could be achieved with
a depolarizing high KCl stimulus (60 mM, 5 min; data not shown).
For analysis of single GABAAR dynamics, trajectories were created
automatically from movies of QD-tagged receptors. For each frame, an
image segmentation algorithm was run that classifies image pixels based
on their local symmetry at a specified scale. Pixels with maximal rota-
tional symmetry (corresponding to local maxima in intensity) were clas-
sified as being attributable to QDs, and their locations were given to
subpixel accuracy by taking the weighted average of connected target
pixels. The pointing accuracy of the system is 50 nm. Tracks were
generated by linking particle positions between frames, using homemade
software written in Mathematica (Wolfram Research). Briefly, the Eu-
clidian distance between frames was minimized using a function that
allowed for particle blinking such that tracks could be connected across
blinking events. Instantaneous diffusivities (Dinst) were calculated from
interframe displacements along consecutive track segments according to
the 2D diffusion law (x 2 4Dinstt), and fitting to the first five points of
the displacement curve was used to estimate the instantaneous diffusion
coefficient. QD track segments were classified as being inside clathrin-
coated pits (labeled by clathrin–YFP) if theirmidpointwaswithin 0.4m
of the center of a pit. Cluster positions were found automatically from
images taken immediately before the corresponding QDmovie using the
image segmentation algorithm described above. For imaging at inhibi-
tory synapses, QD track segments were classified as synaptic if their mid-
point was within 0.75 m of the center of a VGAT punctum.
Statistical analysis.All experiments were performed at least three times
from different preparations. Unless otherwise stated, p values given are
from two-tailed t tests, and values are given as mean SEM. Error bars
represent SEM.
Results
AP2 binds to a patch of basic amino acid residues within the
3-subunit ICD
Little is currently known regarding the dynamics of GABAARs at
EZs in neuronal dendrites for their subsequent endocytosis. Re-
cruitment of GABAARs to these sites is likely to depend on direct
associations between the 2 subunit of the clathrin adaptor AP2
(2–AP2) and GABAAR-subunit ICDs (Kittler et al., 2005). To
allow us to study the role of GABAAR 3 subunits in regulating
the dynamics of GABAAR endocytosis, we set out to identify 3-
subunit mutants no longer able to directly bind 2–AP2. To this
end, we made multiple GST fusion proteins of the 3-subunit
ICD with sequential regions of the ICD deleted (Fig. 1A) and
tested their ability to bind in vitro translated 35S-labeled2–AP2.
Quantification of the radioactive protein bound to the various
GST–3 ICD deletions revealed that the binding of 2–AP2 to
deletion 6 (395–414) was significantly reduced compared with
binding to the other GST–3 ICD deletions (n  5, *p  0.05;
Fig. 1B,C). To ascertain whether a similar loss of binding was
observed for 2–AP2 from brain, we used a similar pull-down
approach to assess the binding of GST–3 deletion proteins to
2–AP2 from rat brain homogenate. In agreement with our find-
ings using radiolabeled 2–AP2, the binding of brain 2–AP2 to
deletion 6 was significantly reduced compared with the other
GST–3 deletion proteins (n 4, *p 0.05; Fig. 1D,E), further
confirming that the region deleted in GST–3 deletion 6 is im-
portant for the binding of 2–AP2 to the 3-subunit ICD.
The 20 aa region identified in Figure 1A–E (deletion 6) con-
tains a stretch of amino acids enriched with basic lysine and ar-
ginine residues, similar tomotifs identified in other AP2-binding
membrane proteins, including synaptotagmin-1 (Syt-1) (Haucke
et al., 2000), the 1-adrenergic receptor (Diviani et al., 2003)
and AMPA receptors (Kastning et al., 2007). To determine
whether these residues within the 3 subunit (400KKTHL-
RRR407) were responsible for AP2 binding, we mutated the basic
amino acidswithin this region to alanines (GST–37A; Fig. 1F). A
dileucine motif within the 2 GABAAR-subunit ICD has also
been suggested to be a determinant of clathrin-dependent inter-
nalization of the receptor (Herring et al., 2003). To verifywhether
a conserved dileucine motif in the 3-subunit ICD was also im-
portant for AP2 binding, we also mutated this motif to alanine
(Fig. 1F), to give GST–3ILL/AAA, and additionally constructed a
double mutant, GST–37AILL/AAA with both sites mutated.
These fusion proteins were used in pull-down assays with 35S-
labeled 2–AP2 to analyze the effect of these specific mutations
on the AP2/3 ICD interaction. Mutation of the seven basic res-
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idues greatly reduced binding of 2–AP2 to the 3-subunit ICD
by threefold (n 3, **p 0.01; Fig. 1G,H), to a similar level to
the binding of 2–AP2 to 3 deletion 6 (3395–414). However,
themutation of the dileucinemotif to alanines had no significant
effect on the binding of 2–AP2 to the 3 ICD, and mutation of
both motifs (37AILL/AAA) had a similar effect to the 7Amutant
alone, suggesting that the dileucine motif does not significantly
contribute to the interaction with 2–AP2. These experiments
also corroborate the results from Figure 1B–E, which show no
decrease in binding to AP2 with deletion 3, which contains the
putative dileucinemotif. Similar results were obtained frompull-
down experiments with rat brain homogenate with binding of
2–AP2 to the 3 ICDmutants mirroring the in vitro pull-down
assays (n  6, *p  0.05; Fig. 1 I, J). These results support a key
role for a 7 aa motif ( 400KKTHLRRR407) within the GABAAR
3-subunit ICD in mediating the interaction with AP2.
Molecular determinants of the 3-subunit/AP2 interaction
To further identify the key residues within the 400KKTHLRRR407
motif that mediate AP2 binding, we sequentially mutated the
seven basic amino acids (shown in Fig. 2A) within GST–3 ICD
to alanine, generating GST–3KK/AA, GST–3TH/AA, and GST–
3RRR/AAA mutants, which were then used in pull-down experi-
ments with rat brain homogenate (Fig. 2B). Quantification of
AP2 binding by densitometry showed a large decrease in the
binding of AP2 to the GST–3RRR/AAA mutant compared with
the binding to theGST–3WT, GST–3KK/AA, andGST–3TH/AA
fusion proteins (n 3, *p 0.05; Fig. 2C), suggesting that these
three arginine residues are essential for the binding of the3 ICD
to AP2. AP2 comprises a heteromer of , 2, 2, and 2 adaptin
subunits (Collins et al., 2002). We further confirmed that the
RRR motif mediates interaction with heteromeric AP2 endoge-
nous complexes as revealed by WB with a 2 adaptin antibody
Figure 1. Identification of the interaction domain within the GABAAR3-subunit ICD that mediates association with AP2. A, Schematic showing deletions within the GABAAR3-subunit ICD.
B, In vitro translated 35S-labeled2 was subjected to pull-down experiments with deletion3 ICD GST fusion proteins. IN, Input. C, Quantification of2 binding shows a significant decrease in
binding to deletion 6 (395–414) (n 5, *p 0.05).D, Pull-down experimentswith rat brain lysatewith the deletion3 ICD GST fusion proteins. Protein complexeswere analyzed by SDS-PAGE
and Western blotting with an antibody to AP2. E, Densitometric quantification of endogenous AP2 binding to deletion 3 ICDs reveals a significant decrease in binding of AP2 to deletion 6
(395–414) (n 4, *p 0.05). F, Amino acid sequence of the GABAAR3-subunit ICD. Deletion 6 (395–414) is shown by the black line. Basic residues thatmay be a putative AP2 binding site
are highlighted in dark gray and aremutated to alanine in the3 7Amutant construct. A putative dileucinemotif is highlighted in light gray. G, In vitro translated 35S-labeled2was subjected to
pull-down experiments with 3-subunit mutant GST fusion proteins. H, Quantification of 2 binding showing that the mutation of seven basic residues (3 7A) within the region 395–414
significantly reduces bindingof2 to the3 ICD (n3, **p0.01). I, Pull-downexperiments in rat brain lysatewith thedeletion3-subunitmutantGST fusionproteins. Protein complexeswere
analyzed by SDS-PAGE and Western blotting with an antibody to AP2. J, Quantification of endogenous AP2 binding to 3-subunit mutant ICDs showing the mutation of seven basic residues
significantly reduces the binding of endogenous AP2 to the3 ICD (n 6, *p 0.05), but the mutation of the dileucine motif has no significant effect on AP2 binding.
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(Fig. 2B). Direct binding of2–AP2 to theRRRmotif was further
confirmed by in vitro pull-down assays using GST–3WT and
GST–3RRR/AAA with bacterially expressed His–2 (Fig. 2D),
which also showed a large decrease in the direct binding of His–
2–AP2 to GST–3RRR/AAA compared with GST–3WT.
The amino acid residueswithin the2 subunit of AP2 respon-
sible for the interaction with the 3 ICD are not known. Atypical
basic-patchmotif containingmembrane cargo (such as Syt-1) are
known to interact with subdomain B of 2–AP2 (residues 283–
394). In the case of Syt-1, key residues within this region of 2–
Figure 2. Molecular determinants of the AP2/GABAAR3-subunit interaction. A, Sequence of the basic amino acid stretch of the3-subunit ICD showing the basic amino acids (red) and their
sequentialmutation to alanine residues (blue).B–D, The arginine residues in the3 subunitmediate its interactionwith AP2.B, Pull-down experiments in rat brain lysatewithWT, KK, TH, and RRR
3 ICD mutant GST fusion proteins. Protein complexes were analyzed by SDS-PAGE andWestern blotting with antibodies to the2 and2 subunits of the AP2 complex. C, Quantification of AP2
binding by densitometry showed a large 3.6-fold decrease in binding toGST–3 RRR/AAA (n 3, *p 0.05),whereas therewas no significant decrease in binding to the KK or THmutants.D, In vitro
pull-down experiments with the3-subunit mutant GST fusion proteins with and without His–2. Protein complexes were analyzed by SDS-PAGE and stained with Coomassie blue. E, In vitro
pull-down experimentswith the3-subunit GST fusion protein andWTHis–2 and lysinemutants of His–2. Protein complexeswere analyzed by SDS-PAGE and stainedwith Coomassie blue. F,
G, The3-subunit ICD and EGFR bind distinct regions of2–AP2. F, In vitro pull-down experiments with Syt-1–GST,3–GST, EGFR–GST, and GST as a control, andWT His–2, K354E–His–2,
and Syt-1mut–His-2 (which is incapable of binding to Syt-1). Protein complexes were analyzed by SDS-PAGE and stained with Coomassie blue. G, SPR sensograms showing binding of WT and
mutant His–2 to3-basic patch and FYRALM peptides, demonstrating that the K354E mutation in2 reduces its affinity for the3 peptide but not for the EGFR peptide. KD values are given in
the figure. N/D, No interaction was detectable. RU, Response units.
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AP2 are important for the binding of Syt-1 (Haucke et al., 2000).
We therefore tested the binding of His–2, containing a series of
lysine (K) residue mutations, to the GST–3 fusion protein by
performing pull-down assays with variants of 2 containing key
K residues in subdomain Bmutated (Fig. 2E). These experiments
revealed thatmutation of K354 to glutamate (E) withinHis–2 is
sufficient to abolish its binding to the 3 ICD (Fig. 2E), suggest-
ing that this residue is critical for 3-subunit—AP2 complex
formation. To support this finding, additional pull-down exper-
iments were performed with wild-type His–2, mutant K354E–
His–2 (its binding to 3 abolished), and, as an additional
control, His–2–Syt-1mut (with key additional subdomain B
residues mutated preventing its binding to Syt-1: K343A, Y344A,
K345E, E348A, K354E, and K356E) and GST–3 (Fig. 2F). This
revealed that the K354E–His–2 andHis–2–Syt-1mutmutants
exhibited significantly reduced binding to GST–3 (and with
GST–Syt-1, as a control) but could still interact with GST fusion
protein of the C-terminal tail of the EGF receptor (EGFR) (resi-
dues 995–1045), which associates with a different region of 2–
AP2 via tyrosine-based endocyticmotifs (Owen and Evans, 1998)
(Fig. 2F). The key role of His–2 for 3 binding was further
supported by SPR experiments that compared the binding affin-
ities of His–2 and His–2–K354E to a 401KTHLRRRSS409 pep-
tide (the 3 ICD basic patch motif) or FYRALM peptide (an
EGFR-derived tyrosine-based endocytic motif). Both endocytic
sortingmotif peptides bind towild-typeHis–2with a similarKD
value of1M. In agreementwith theGSTpull-downs (Fig. 2F),
the SPR experiments showed that the 2 K354E mutation selec-
tively prevents binding to the basic atypical motif within the 3
ICD but not to the tyrosine motif within the EGFR peptide (Fig.
2G). These observations lead to the conclusion that the GABAAR
3-subunit binds 2–AP2 via a minimal 405RRR407 motif, to a
domain within 2–AP2, which is distinct from the C-terminal
pocket region of 2–AP2 that binds tyrosine-based motifs such
as those within EGFR.
AP2–3-subunit interactions stabilize GABAARs at EZs but
not synapses
Having identified a key AP2-binding site in GABAAR 3 subunits,
we proceeded to investigate the role of 3-subunit-mediated AP2
binding for regulating the dynamics of GABAARs at EZs in hip-
pocampal neuronal dendrites. As a prelude to investigating the role
of AP2 adaptor interactions in stabilizing GABAARs to EZs, we ini-
tially characterized the membrane dynamics of 3-subunit-
containing receptors indendriteswith respect toEZs.To test this,we
visualized single GABAAR-containing myc-epitope-tagged wild-
type GABAAR (
myc3WT) subunits, using QD tracking (Muir et al.,
2010), awell-establishedmethod for following thebehavior of single
receptors in the surface membrane (Triller and Choquet, 2008). To
examine GABAARmobility using thismethod in relation to regions
of endocytosis in the neuronal plasma membrane, we simultane-
ously labeled EZs by cotransfecting neurons with YFP-tagged clath-
rin light chain, which has been used previously to label these
subdomains in dendrites (Blanpied et al., 2002; Petrini et al., 2009).
Singlemyc-taggedGABAARswere labeledusinga lowconcentration
of rabbit anti-myc antibody in conjunction with an anti-rabbit sec-
ondary coupled to 605 nm QDs. Single QD-labeled myc3WT-
containing GABAARs could be observed to rapidly diffuse into and
out of EZs (Fig. 3A,B) and were less mobile when at EZs compared




We then used QD tracking of mutant GABAARs to directly in-
vestigate the role of interactions with the AP2 complex on receptor
lateral mobility at EZs. Strikingly, the lateral mobility of mutant
myc3RRR/AAA-containing GABAARs inside EZs was 3.3-fold higher




1016, Kolmogorov-Smirnov (K–S) test (Fig. 3C); myc3RRR/AAA
median Dout  0.032,
myc3WT median Dout  0.020 m
2s1,
***p 2.2 1016 (Fig. 3D)]. In agreement withmutant receptors
being less stable at EZs, mutation of the three arginine residues
caused a significant decrease in themean time spent byGABAARs at
EZs (myc3WT, 0.81  0.18 s, n  12 cells; myc3RRR/AAA, 0.42 
0.03 s, n 11 cells; *p 0.05), suggesting thatmutation of the RRR
motif disrupts the interaction required to stabilizeGABAARs at den-
dritic EZs before their endocytosis.
We also investigated the mobility and residency time of individ-
ual myc3RRR/AAA- containing GABAARs at inhibitory synapses. In-
hibitory presynaptic terminalswere live labeledusing an antibody to
the luminal domain of theGABA transporter VGAT, coupled to the
fluorophoreOyster-488 (Martens et al., 2008), which we confirmed
were GAD-6 positive (Fig. 3E,F). QD–GABAAR trajectories were
analyzed inside and outside of synaptic locations (as determined by
VGAT puncta). Both myc3WT- and myc3RRR/AAA-containing
GABAARs were slower at synapses compared with their extrasynap-
tic counterparts. Inside synapses, myc3WT and myc3RRR/AAA lat-
eral mobility was very similar (myc3WT median D  0.00882
m2s1; myc3RRR/AAA median D  0.00887 m2s1; p  0.77,
K–S test), suggesting that theRRRmotif is not important in stabiliz-
ing receptors at synapses.Outside synapses, myc3RRR/AAA receptors
were 1.3-fold more mobile than myc3WT receptors (myc3WTme-
dian D  0.0137 m2s1; myc3RRR/AAA median D  0.0180
m2s1; ***p 2 1016, K–S test). This is likely attributable to
the fact thatEZs (atwhichmutant receptors are faster thanwild-type
receptors) are found extrasynaptically. In agreement with the find-
ing that wild-type andmutant receptormobilities are similar at syn-
apses, we found no difference in the mean time spent by these
receptors at synapses (myc3WT, 1.29  0.22 s, n  14 cells;
myc3RRR/AAA, 1.36 0.33 s, n 11 cells; p 0.70). Together, these
experiments show the RRR AP2-binding motif in the 3 subunit is
important in regulating GABAAR stabilization at EZs but does not
affect the stabilization of individual receptors at inhibitory synapses.
Mutation of three arginine residues within the -subunit ICD
impairs GABAAR endocytosis
We predicted that, because myc3RRR/AAA mutant-containing
GABAARs are less efficiently recruited to EZs and spend less time
at these sites, the endocytosis of these mutant receptors would be
disrupted. To test this, we performed antibody feeding experi-
ments with COS-7 cells expressing 1myc3WT or 1myc3RRR/AAA
GABAARs and GFP (Fig. 4A). Quantification of GABAAR internal-
izationbynormalizationof the internalized receptor area to the total
cell area (as given by GFP fluorescence, arbitrary units) revealed a
significant decrease in 1myc3RRR/AAA receptor endocytosis
(0.78  0.07) compared with 1myc3WT receptors (2.92  0.50,
n 3, *p 0.05). Similar antibody feeding assays were performed
on COS-7 cells cotransfected with other 3-subunit mutants ana-
lyzed for AP2 binding in Figure 1 (myc37A, myc3ILL/AAA,
myc37AILL/AAA, and myc3395–414). COS-7 cells expressing the
1myc37A (0.47  0.22), 1myc37AILL (0.68  0.11), and
1myc3395–414 (0.56 0.21) mutant GABAARs all displayed sig-
nificantly reduced endocytosis levels compared with 1myc3WT
and 1myc3ILL/AAA receptors (1myc3WT, 1.5  0.3;
1myc3ILL/AAA, 1.47 0.3; n 3, *p 0.05; Fig. 4B).
In similar experiments with COS-7 cells cotransfected with
RFP–rab5, an early endosomal marker (Fig. 4C), quantification
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of the colocalization of internalized receptors with rab5-labeled
compartments revealed that RRR mutant GABAARs displayed
significantly decreased colocalization with rab5 compared with
WT receptors (myc3WT, 24.0  0.4%; myc3RRR/AAA, 12.5 
1.4%; n 4, **p 0.01; Fig. 4C). This was also the case with the
other mutant receptors, revealing decreased colocalization with
rab5-labeled compartments for the 1myc37A, 1myc3ILL/AAA,
and 1myc3395–414 receptors [1myc37A, 13.17  0.55%
(*p 0.05);1myc37AILL/AAA, 20.02 3.21% (*p 0.05); and
1myc3395–414, 9.48  1.50% (**p  0.01)] compared with
their wild-type counterparts (30.42 1.53%; Fig. 4D). However,
1myc3ILL/AAA mutant receptors displayed almost identical lev-
els of colocalization with rab5 as wild-type receptors (30.68 
2.98%, p 0.7), suggesting that the dileucinemotif does not play
a significant role in the endocytosis of13-containing receptors
to the early endosome compartment in COS-7 cells.
To also test whether a similar mechanism of GABAAR endo-
cytosis occurs in neurons, we transfected neurons with myc3WT
or myc3RRR/AAA constructs, which assemble with endogenous
subunits in neurons (data not shown), and performed a similar
Figure 3. Interactionswith AP2 stabilize GABAARs at EZs.A, Trajectories of QD-tagged
myc3WT subunits (orange) shown overlaid onto the location of clathrin–YFP-labeled EZs (inwhite). Scale
bar, 5m; imaging duration, 23.5 s. Arrows indicate examples in which QD-tagged GABAARs are within EZs. B, As in A but for QD-tagged
myc3 RRR/AAA subunits. C, Cumulative frequency plots of
the instantaneous diffusion coefficients for QD-tagged myc3WT (solid line) and myc3 RRR/AAA (dashed line) subunits inside EZs as marked by clathrin–YFP. GABAARs containing
myc3 RRR/AAA
subunits are 3.3-fold more mobile than myc3WT within EZs (***p 2.2 1016, K–S test; myc3WT nin 13,785;
myc3 RRR/AAA nin 10,836). D, As in C, for
myc3WT (solid line) and
myc3 RRR/AAA (dashed line) subunits outside EZs. GABAARs containing 3 subunits with RRR/AAA mutation are 1.63-fold more mobile than WT outside EZs (***p 2.2 10
16, K–S test;
myc3WTnout150,884;
myc3 RRR/AAAnout200,986).E, Sectionof exampleneuron showingGABAergic terminals loadedwithVGAT-Oyster 488.F, Dendrite of neuronwithGABAergic terminals
loadedwith VGAT-Oyster 488 and stainedwith GAD-6 antibody.G, QD-tagged GABAAR trajectories (orange) shown overlaid on VGAT loading (inhibitory synapses) for
myc3WT receptors (top) and
myc3 RRR/AAA mutant receptors (bottom). Arrows point to trajectories in synaptic areas. H, Cumulative frequency plots of instantaneous diffusion coefficients for myc3WT and myc3 RRR/AAA
receptors at synapses (positions given by VGAT loading). Mobilities at inhibitory synapses are not significantly different ( p 0.77, K–S test; myc3WT nin 10,341;
myc3 RRR/AAA nin 8250). I,
As in H but for extrasynaptic regions. myc3 RRR/AAA receptors are 1.3-fold more mobile extrasynaptically ( p 2 1016, K–S test; myc3WT nout 127,452;
myc3 RRR/AAA nout 91,211).
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Figure 4. Mutation of the RRRmotif impairs GABAAR endocytosis and causes their surface accumulation.A, COS-7 cells coexpressing GABAARs (1
myc3 or1myc3 RRR/AAA) and GFPwere live
labeled with anti-myc antibody and placed at 37°C for 30 min to allow internalization of receptors. Remaining surface antibody was stripped away and cells were fixed, (Figure legend continues.)
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antibody feeding protocol. Surface receptors were labeled with
myc antibody, left to internalize at 37°C for 30 min, and then
fixed and blocked under nonpermeabilizing conditions. Surface
receptors were labeled with Alexa Fluor 488-conjugated second-
ary antibody (green; surface), and, after permeabilization, all
myc-tagged receptors were labeled with Alexa Fluor-594-
conjugated secondary antibody (red; total), enabling the inter-
nalized receptors to be quantified (Fig. 4E). Quantification of the
internalized pool of receptors (red fluorescence) showed a 72.0
5.0% decrease in the endocytosis of the mutant myc3RRR/AAA-
containing GABAARs compared with wild-type receptors (n 3,
**p 0.01; Fig. 4E), suggesting that the RRRmotif is essential for
GABAAR internalization in neurons. Neurons expressing
myc37A, myc37AILL/AAA, and myc3395–414 mutants also ex-
hibited a similar decrease in percentage endocytosis (myc37A,
78.14 4.70%; myc37AILL/AAA, 62.14 6.06%; myc3395–414,
74.24  5.00% decrease in the extent of receptor endocytosis
compared with myc3WT control levels; n  3, **p  0.01; Fig.
4F, images not shown). In contrast, the myc3ILL/AAA mutant
subunits were not significantly altered in their endocytosis com-
pared with myc3WT-subunit-containing receptors (32.03 
26.23% decrease, p  0.3). Therefore, in both COS-7 cells and
neurons, themutation of the RRRmotif within the 3 subunit to
alanine residues disrupts the endocytosis of GABAARs.
In agreement with these findings, whole-cell ELISAs (Bedford
et al., 2001; Mielke andWang, 2005) in cortical neurons express-
ing either myc3WT or myc3RRR/AAA constructs revealed that
neurons transfected with the myc3RRR/AAA mutant displayed a
significant 61.6 8.0% increase in surface GABAARs compared
with neurons expressing myc3WT receptors (n 3, **p 0.01).
To support these data, we then used confocal microscopy to
quantify the total area of GABAAR clusters in neurons expressing
either the myc3WT or myc3RRR/AAA constructs. Similarly, the
total area of GABAAR clusters in neurons expressing the
myc3RRR/AAAmutant was 68.0 28.2% greater than that of neu-
rons expressing the myc3WT construct (n  3, **p  0.01; Fig.
4G). Therefore, mutation of residues (405RRR407) within the 3
subunit leads to steady-state accumulation of GABAARs at the
cell surface and at synapses as a result of a decrease in clathrin-
dependent endocytosis.
The observed alterations in surface levels and lateral mobility
of myc3RRR/AAA mutant GABAARs could also possibly be attrib-
utable to the effects of NSF, an ATPase that binds to a potentially
overlapping region of the 3 ICD as AP2 (Goto et al., 2005) and is
implicated in GABAAR trafficking (Chou et al., 2010). To confirm
thatNSF functionwasnot involved in theobserved increased surface
expression of myc3RRR/AAA mutant GABAARs, we treated COS-7
cells expressing1myc3WTor1myc3RRR/AAAGABAARswith an
NSF inhibitory peptide (NSFi; fused to the TAT sequence),
shown previously to increase GABAAR surface expression, or a
scrambled control peptide (Morrell et al., 2005; Chou et al.,
2010). ELISA experiments were then used to verify surface
GABAAR levels. The NSFi peptide treatment caused a 35.3 
7.2% increase in surface 1myc3WT GABAARs compared with
scrambled peptide treatment (Fig. 4H). A similar effect on NSF
inhibition was also observed for surface 1myc3RRR/AAA
GABAARs [47.7  14.08% increase in surface 1
myc3RRR/AAA
GABAARs on NSFi treatment compared with scrambled peptide
treatment (n  4, *p  0.05)]. These results confirm that the
myc3RRR/AAA mutant still undergoes regulatory control by NSF-
dependent trafficking mechanisms and that the observed in-
crease in surface myc3RRR/AAA mutant expression is not
attributable to altered regulation by NSF via this motif. NSF-
dependent interactions were also unlikely to play a role in the
observed alterations in surface GABAAR lateral mobility of mu-
tant 3RRR/AAA receptors, because QD-imaging experiments re-
vealed that blocking NSF activity had very little effect on the
lateral mobility of GABAARs at the plasma membrane (data not
shown). We therefore conclude that the effects of the RRR/AAA
mutation on GABAARs at the neuronal cell surface are attribut-
able to the specific disruption of the 3/AP2 binding site.
3-subunit AP2 interactions are critical for GABAAR
depletion from synapses during ischemic insult
An imbalance between excitatory and inhibitory synaptic trans-
mission is thought to contribute to excitotoxicity and neuronal
cell death during ischemic insult. Several studies have reported a
decrease in surface and synaptic GABAAR expression during
ischemia, suggesting an increase in receptor endocytosis
(Schwartz-Bloom and Sah, 2001; Mielke and Wang, 2005; Zhan
et al., 2006; Kelley et al., 2008; Arancibia-Ca´rcamo et al., 2009; Liu
et al., 2010), but whether this is via an AP2-dependent pathway
remains unclear.
To monitor the role of AP2 interactions in GABAAR traffick-
ing, we used a super-ecliptic pHluorin (pH-sensitive GFP)
N-terminally tagged 2-subunit construct (SEP2), cotransfected
with 3 subunits to visualize surface and synaptic GABAAR clus-
ters under normal and ischemic conditions using live-cell imag-
ing techniques. This cotransfection also enabled us to study
effects of mutations within both 2 and 3 subunits. Hippocam-
pal neurons were cotransfected with SEP2, 1, and either the
myc3WT or the AP2-binding-deficient myc3RRR/AAA or myc37A
constructs. Quantification of the cotransfection efficiency of these
DNAsrevealed that93.33.3and96.63.3%of SEP2-transfected
cells were cotransfected with myc3WT or myc3RRR/AAA, respec-
tively, indicating a high and similar level of cotransfection for
these experiments (data not shown). Similar transfection effi-
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Figure 4. (Figure legend continued) permeabilized, and labeled with secondary antibody.
Quantification of GABAAR endocytosis by normalization of the internalized receptor area to the
total cell area (as given byGFP fluorescence) showeddecreased internalization ofmyc3 RRR/AAA
receptors compared with myc3WT receptors (myc3WT, 2.92 0.50; myc3 RRR/AAA, 0.78
0.07; n 3, *p 0.05). B, Summary of data from similar antibody feeding experiments with
myc3WT, myc3 7A, myc3 ILL/AAA, myc3 7AILL/AAA, and myc3395–414 containing
GABAARs. C, Antibody feeding experiments in COS-7 cells coexpressing GABAARs (1
myc3WT
or1myc3 RRR/AAA) and RFP–rab5. Receptor internalization wasmeasured as the percentage
colocalization of receptors with rab5 and showed a 50% decrease in internalization of
1myc3 RRR/AAA mutant GABAARs compared with wild-type receptors (
myc3WT, 24.0 
0.4%; myc3 RRR/AAA, 12.5 1.4%; **p 0.01, n 4). D, Summary of data from similar
antibody feeding experiments with myc3WT, myc3 7A, myc3 ILL/AAA, myc3 7AILL/AAA, and
myc3395–414 containing GABAARs. E, DIV 12–14 neurons expressing
myc3WT or myc3RRR/AAA
subunitswere treatedwith anantibody feedingprotocol. Fluorescenceof internalized receptors
was represented as a fraction of the total fluorescence of the cell and normalized to values for
myc3WT-transfected cells. Red fluorescence indicates internalized receptors. The internaliza-
tion of myc3 RRR/AAA-containing receptors was reduced to 28.0  5.0% compared with
myc3WT receptors (n 3, **p 0.01). Arrows point to internalized receptor population
(red). F, Quantification of similar antibody feeding experiments in neurons expressing
myc3 7A, myc3 ILL/AAA, myc3 7AILL/AAA, and myc3395–414 receptors. Scale bars, 20m.
G, Cluster counting analysis of 25m dendritic segments of neurons expressing myc3WT or
myc3 RRR/AAA revealed a 68.0 23.2% (n 3, **p 0.01) increase in total surface receptor
cluster area. Scale bar, 5 m. H, ELISA experiments were performed with COS-7-expressing
1myc3WT or1myc3 RRR/AAA GABAAR subunits that were treated with either an NSFi or a
scrambled control peptide (Scram). The NSFi peptide caused a 35.3 7.2% increase in surface
1myc3WT GABAARs and a 47.7 14.08% increase in surface 1
myc3 RRR/AAA GABAARs
(n 4, *p 0.05).
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ciencies were also obtained for the myc37A construct (data not
shown).
We imaged SEP2 and myc3WT cotransfected 12–15DIV hip-
pocampal neurons under control conditions or under conditions
of OGD, an in vitro experimental model used to mimic cerebral
ischemia (Kelley et al., 2008; Arancibia-Ca´rcamo et al., 2009).
The fluorescence of individual SEP2 clusters in neuronal den-
drites was imaged over a 30 min time period. Analysis of SEP2
cluster fluorescence in neurons cotransfected with myc3WT
showed that the SEP2 cluster fluorescence remained stable under
control conditions (Fig. 5A,B). However, during the OGD treat-
ment, there was a significant 21.3 4.0% reduction in surface clus-
ter fluorescenceover time comparedwith the control (n12, **p
0.01; Fig. 5A,B). Using this approach, we then investigated whether
this downmodulation was dependent on 3-subunit/AP2 interac-
tions. In contrast to the myc3WT/SEP2-containing receptors, the sur-
face SEP2 cluster fluorescence was not reduced onOGD treatment in
neurons cotransfectedwith either the myc37A or myc3RRR/AAAmu-
tant subunitswith impairedendocyticability (p0.71andp0.36,
respectively; Fig. 5C–F,I).
A GABAAR AP2-binding domain (YECL) in the 2 subunit
also exists (Kittler et al., 2008). In contrast, mutating the YECL
AP2-binding domain in the 2 subunit (to AECL) led to signifi-
cant decrease in GABAAR cluster intensity under OGD condi-
tions (*p  0.05; Fig. 5G,J). However, in neurons cotransfected
with myc3RRR/AAA and SEP2AECL, GABAARs were stable at the
cell surface over the OGD time course (p  0.77; Fig. 5H, J).
Thus, the RRRmotif within the3 subunit is more important for
control of AP2-mediated GABAAR internalization during OGD
insult than the YECL motif on the 2 subunit. Therefore, these
experiments show that the interaction of the3 subunit withAP2
plays a key role in the loss of synaptic GABAARs observed during
ischemia. Furthermore, these data reveal that specific targeting of
this GABAAR RRR AP2-binding motif could provide resistance
for GABAARs against their accelerated endocytosis and removal
from synaptic sites induced by ischemic insult.
Blockade of the3/AP2 interaction reduces neuronal cell
death during ischemic insult
We have revealed that preventing the interaction of GABAAR 3
subunit and AP2 can maintain surface GABAAR clusters during
OGD. To investigate the functional relevance of this finding, we
used a peptide overlapping the AP2 binding region in the 3
subunit to compete the 3/AP2 interaction in hippocampal neu-
rons (3 peptide). The 3 peptide and a control peptide (to a
region of the 3 ICD distinct from the AP2 binding site) were
transduced into 12–15 DIV hippocampal neurons for 1 h before
OGD insult using amembrane-permeable carrier peptide (Twel-
vetrees et al., 2010). Delayed neuronal death was analyzed 24 h
later using PI and DAPI staining, and the number of PI-positive
nuclei were counted and the cell viability determined (Fig. 6A,B).
OGD treatment of neurons transduced with the control peptide
caused a 30.5  1.6% decrease in cell viability (n  3, ***p 
0.001) compared with neurons pretreated with the 3 peptide
that exhibited an insignificant 6.4  1.4% reduction in cell via-
bility (n 3, p 0.09). These data show that specifically blocking
the 3/AP2 interaction in neurons can prevent OGD-induced
delayed cell death, strongly suggesting that GABAAR endocytosis
via the RRR motif is important in mediating this process.
Discussion
Regulated trafficking of postsynaptic neurotransmitter recep-
tors is essential for determining the strength of synaptic trans-
mission and for ensuring the correct balance of excitation and
inhibition of neuronal circuits (Groc and Choquet, 2006;
Arancibia-Ca´rcamo and Kittler, 2009). Tightly controlled
clathrin-dependent endocytosis of surface GABAARs has been
specifically shown to control synaptic efficacy in neurons, pro-
viding a fastmechanism tomodulate synaptic strength and there-
fore synaptic inhibition (Kittler et al., 2000, 2008). Reduced
inhibition attributable to alterations in GABAAR trafficking can
also contribute to disrupted information processing and to the
detrimental excitotoxicity thought to exacerbate neuronal cell
death observed in conditions such as stroke and epilepsy (Smith
and Kittler, 2010). In this study, we have investigated the inter-
nalization mechanisms of 3-subunit-containing GABAARs un-
der normal and pathological conditions. We have identified a
specific RRR motif (405RRR407) within the 3-subunit ICD that
is essential for the endocytosis of GABAARs. We show that these
residues mediate the direct interaction with 2–AP2, although
K354within2–AP2 is also critical for this interaction.Mutation
of the3-subunit RRRmotif reduces recruitment ofGABAARs to
EZs and impairs their endocytosis, leading to their steady-state
accumulation at the neuronal cell surface and at synapses. We
also show that downmodulation of GABAARs from dendritic
clusters during OGD treatment (to simulate ischemia) is depen-
dent on an AP2-dependent pathway for cell-surface removal of
receptors. Moreover, blockade of this pathway can reduce the
delayed neuronal death observed during ischemic insult.
We focused our study on the internalization ofGABAARs con-
taining the 3 subunit because of its high expression in the hip-
pocampus and cortex and its presence in a large proportion of
GABAAR subtypes found in these regions (Laurie et al., 1992;
Wisden et al., 1992). To identify the molecular determinants of
GABAAR internalization, we first identified the region of the 3-
subunit ICD that mediated the interaction with the clathrin-
adaptor protein AP2. This revealed a 20 aa stretch that harbored
a seven residue atypical basic patch motif that, when mutated to
alanine, prevented the binding of AP2 to the GABAAR 3-
subunit ICD. Within this binding motif, additional mapping
identified three arginine residues (405RRR407) that are essential
for the interaction with 2–AP2 and receptor internalization via
an AP2- and clathrin-dependent mechanism. Because 2–AP2
binds to GABAAR subunits 1–3 and the RRR motif is con-
served across all three  subunits, it suggests that these residues
might be an internalization signal for all -subunit-containing
GABAARs. An arginine residue (R845) was also shown to be crit-
ical for AMPA receptor GluR2 subunit binding to AP2 (Lee et al.,
2002; Kastning et al., 2007). Atypical basic patch motifs of both
AMPA and GABAARs bind to the same region of 2–AP2, sub-
domain B (Kastning et al., 2007; and this study), pointing to a
similar clathrin-mediated internalization mechanism for both
types of postsynaptic neurotransmitter receptors. In contrast, we
did not find that a putative dileucine motif within the 3 subunit
[as suggested for the 2 subunit (Herring et al., 2003)] was re-
quired for endocytosis or AP2 binding, suggesting that this motif
is not a primary determinant of 3-subunit-mediated GABAAR
internalization. Interestingly, the 3-subunit RRR motif is lo-
cated adjacent to a phosphorylation site, Ser408/Ser409, which acts
as a key site for GABAAR phosphomodulation by kinases (Bran-
don et al., 2002) and phosphatases (Jovanovic et al., 2004; Ter-
unuma et al., 2008). Phosphorylation at this site has been shown
to impair GABAAR endocytosis by preventing the interaction of
the 3-subunit with AP2 (Kittler et al., 2005; Jacob et al., 2009).
The addition of phosphate groups to Ser408/Ser409 would create a
large negative charge that may disrupt the local charge interac-
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Figure 5. GABAARs that are unable to bind AP2 are not removed from synapses during OGD. A, C, E, Twelve to 15 DIV hippocampal neurons expressing
SEP2 and myc3WT, myc3 RRR/AAA, or
myc3 7A were imaged over time under control or OGD conditions. Twenty micrometer sections of dendrite are shown. B, D, F, Fluorescent clusters in dendrites were monitored for loss of GFP
fluorescence over time and normalized to t 0. B, myc3WT control t 30min, 0.94 0.04 (n 12); myc3WT OGD t 30, 0.74 0.04 (n 12, **p 0.01). D, myc3 RRR/AAA control t
30min, 0.87 0.05 (n 7); myc3 RRR/AAA OGD t 30, 0.89 0.03 (n 6, p 0.71, nonsignificant). F, myc3 7A control t 30min, 0.95 0.04 (n 4); myc3 7A OGD t 30, 1.02 0.05
(n 6, p 0.36, nonsignificant). Arrows point to SEP2 clusters.G,H, Twelve to 15 DIV hippocampal neurons expressing SEP2 AECL with either myc3WT or myc3 RRR/AAA subunits were imaged
over time under OGD conditions.G, myc3WT/ SEP2 AECL control, 0.90 0.03, n 5; OGD, 0.75 0.05, n 5; *p 0.05.H, myc3 RRR/AAA/ SEP2 AECL control, 0.89 0.04, n 5; OGD, 0.91
0.05, n 8; p 0.77. Twenty micrometer sections of dendrite are shown. I, J, Bar graphs summarizing the fluorescent cluster analysis. Scale bars, 5m.
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tions provided by the arginine residue
cluster, thereby disrupting the AP2 bind-
ing site.
We have used QD tracking to measure
the lateralmobilityofGABAARswithinEZs,
specialized clathrin-rich regions along the
dendritic plasma membrane, which medi-
ate clathrin-dependent endocytosis (Blan-
piedet al., 2002).We found thatQD-labeled
GABAARs could be reversibly recruited to
these clathrin-rich structures in which they
displayed a reduced lateral mobility com-
pared with receptors outside the EZ, sug-
gesting that the receptors are being confined
to these subdomains, before their endocyto-
sis. This is similar to the confined behavior
of GABAARs observed at the inhibitory
postsynaptic site, with similar diffusion co-
efficient values for themobility of the recep-
tors previously recorded at the synapse to
those observed at EZs (Bannai et al., 2009;
Muir et al., 2010). This suggests that both
inhibitory postsynaptic sites and EZs are
specialized dendritic subdomains that share
similar GABAAR confinement mechanisms
via reversible interactionswith submembra-
nous synapticorEZproteins, suchasgephy-
rinandAP2, respectively. Inagreementwith
this, mutation of the RRR motif to alanine
impaired the recruitment of GABAARs to
EZs, as shownby the 3.3-fold increase in lat-
eral mobility of non-AP2-binding mutant
GABAARs at clathrin-coated pits compared
with their wild-type counterparts. This in-
crease in lateral mobility was accompanied
by a significantly decreased residency time
for the mutant receptors at EZs and a re-
duced likelihood of mutant receptors being
endocytosed. Mutation of the 3-subunit
AP2-binding motif did not alter the mo-
bility or residency time of individual
GABAARs at synaptic sites but did in-
crease the steady-state levels of surface
and synaptic receptors as a result of di-
minished receptor endocytosis. These re-
sults clearly demonstrate the key role of
direct interactions of GABAAR ICDs
with AP2 for recruiting and confining
GABAARs at endocytic sites. This allows
the trapping of mobile receptor popula-
tions at these membrane compartments
within the plasma membrane to enable
GABAARs to eithermediate phasic inhibi-
tion at the synapse or undergo receptor
endocytosis at the EZ.
During cerebral ischemia, overexcitation as a result of exces-
sive glutamate release contributes to excitotoxicity and cell death
in susceptible neuronal populations (Lipton, 1999; Lo et al.,
2003). Research into therapeutics to treat ischemia has focused
primarily on the glutamatergic systemand the reduction of excess
glutamatergic signaling during ischemic insult, but these have
not proven to be clinically effective (Schwartz-Bloom and Sah,
2001). GABAergic transmission and GABAAR endocytosis are
also significantly altered in ischemia, which may contribute to
disinhibition and pathological excitability states. Because gluta-
matergic neurotransmission is counterbalanced by the GABAer-
gic system, modulation of GABA metabolism and GABAAR
function may be alternative targets of therapeutic intervention
for ischemia. An in vitro model of cerebral ischemia, OGD, has
been shown to modulate GABAAR trafficking, reducing surface
expression of receptors (Mielke andWang, 2005; Liu et al., 2010)
Figure 6. Blockade of GABAAR endocytosis reduces OGD-induced delayed cell death. Twelve to 15 DIV hippocampal neurons
were transducedwith control or3peptides for 1hbefore a40minOGD treatment. Twenty-four hours later, neuronswere stained
withPI andDAPI, and thePI-positivenucleiwere counted.A, Representative confocal imagesof control and3peptide transduced
neurons under control and OGD conditions. Scale bar, 40m. B, Bar graph summarizing the pooled data (n 3, ***p 0.001).
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and increasing ubiquitin-dependent lysosomal receptor deg-
radation (Arancibia-Ca´rcamo et al., 2009). Previous studies
using hypertonic sucrose treatment or dynamin inhibitors
have suggested that pathological GABAAR endocytosis in
OGD or status epilepticus is attributable to clathrin-
dependent endocytosis (Goodkin et al., 2005; Mielke and
Wang, 2005). However, hypertonicity has multiple cellular
effects (Rosenmund and Stevens, 1996; Carroll et al., 1999),
and dynamin inhibitors may block other (e.g., caveolar) en-
docytosis pathways (Nabi and Le, 2003; Doherty and McMa-
hon, 2009). By imaging super-ecliptic pHluorin-tagged
GABAARs, we show a decrease in synaptic GABAAR clusters dur-
ing OGD treatment of hippocampal neurons for 30 min, which
is consistent with other studies (Mielke and Wang, 2005;
Arancibia-Ca´rcamo et al., 2009; Liu et al., 2010). Using the 3-
subunit RRRmotifmutant, we then directly tested the pathway of
pathological GABAAR endocytosis during OGD and showed that
acute loss of synaptic GABAARs during OGD is mediated by an
AP2 and clathrin-dependent internalization pathway. Further-
more, blocking this internalization pathway with a competing3
peptide can reduce delayed cell death after OGD insult, demon-
strating the physiological relevance of this mechanism in neuro-
nal function.
We also find that the tyrosine motif within the 2 subunit has
little effect on endocytosis of GABAARs during OGD, suggesting
that the 3-subunit RRR motif is the primary determinant of
internalization during simulated ischemic insult. This is probably
attributable to the different binding affinities of the subunits for
AP2 and their regulation by different kinase families (Kittler et
al., 2005, 2008), allowing multiple signaling pathways to con-
verge at these receptor ICDs, to enable the fine-tuning of endo-
cytosis modulation in response to a variety of extracellular
signals.
In summary, we have identified a triple arginine motif that
mediates direct binding of the GABAAR 3 subunit to the clath-
rin adaptor protein AP2. Mutation of this motif impaired recep-
tor recruitment to clathrin-coated pits, significantly reduced
receptor endocytosis, and caused an accumulation of surface
GABAARs in neurons. This AP2 pathway is likely to play a key
role in regulating synaptic receptor number during inhibitory
synaptic plasticity. In ischemia, synaptic GABAARs are also de-
pleted by this AP2/clathrin-dependent pathway. This internaliza-
tion pathway might therefore also be targeted therapeutically to
maintain surface GABAAR populations and synaptic inhibition
during pathological insults such as epilepsy and ischemic neuro-
nal death.
References
Arancibia-Ca´rcamo IL, Kittler JT (2009) Regulation of GABA(A) recep-
tor membrane trafficking and synaptic localization. Pharmacol Ther
123:17–31.
Arancibia-Ca´rcamo IL, Yuen EY, Muir J, Lumb MJ, Michels G, Saliba RS,
Smart TG, Yan Z, Kittler JT, Moss SJ (2009) Ubiquitin-dependent lyso-
somal targeting of GABA(A) receptors regulates neuronal inhibition.
Proc Natl Acad Sci U S A 106:17552–17557.
Bannai H, Le´vi S, Schweizer C, Inoue T, Launey T, Racine V, Sibarita JB,
Mikoshiba K, Triller A (2009) Activity-dependent tuning of inhibitory
neurotransmission based on GABAAR diffusion dynamics. Neuron
62:670–682.
Bedford FK, Kittler JT, Muller E, Thomas P, Uren JM, Merlo D, Wisden W,
Triller A, Smart TG, Moss SJ (2001) GABA(A) receptor cell surface
number and subunit stability are regulated by the ubiquitin-like protein
Plic-1. Nat Neurosci 4:908–916.
Blanpied TA, Scott DB, Ehlers MD (2002) Dynamics and regulation of
clathrin coats at specialized endocytic zones of dendrites and spines. Neu-
ron 36:435–449.
Bradley CA, Taghibiglou C, Collingridge GL,Wang YT (2008) Mechanisms
involved in the reduction of GABAA receptor alpha1-subunit expression
caused by the epilepsy mutation A322D in the trafficking-competent re-
ceptor. J Biol Chem 283:22043–22050.
BrandonNJ, Jovanovic JN, Smart TG,Moss SJ (2002) Receptor for activated
C kinase-1 facilitates protein kinase C-dependent phosphorylation and
functional modulation of GABAA receptors with the activation of
G-protein-coupled receptors. J Neurosci 22:6353–6361.
Carroll RC, Beattie EC, Xia H, Lu¨scher C, Altschuler Y, Nicoll RA, Malenka
RC, von Zastrow M (1999) Dynamin-dependent endocytosis of iono-
tropic glutamate receptors. Proc Natl Acad Sci U S A 96:14112–14117.
Chen C, Zhuang X (2008) Epsin 1 is a cargo-specific adaptor for the
clathrin-mediated endocytosis of the influenza virus. Proc Natl Acad Sci
U S A 105:11790–11795.
Chen G, Kittler JT, Moss SJ, Yan Z (2006) Dopamine D3 receptors regulate
GABAA receptor function through a phospho-dependent endocytosis
mechanism in nucleus accumbens. J Neurosci 26:2513–2521.
Chou WH, Wang D, McMahon T, Qi ZH, Song M, Zhang C, Shokat KM,
Messing RO (2010) GABAA receptor trafficking is regulated by protein
kinase C and the N-ethylmaleimide-sensitive factor. J Neurosci
30:13955–13965.
Collins BM, McCoy AJ, Kent HM, Evans PR, Owen DJ (2002) Molecular
architecture and functional model of the endocytic AP2 complex. Cell
109:523–535.
Diviani D, Lattion AL, Abuin L, Staub O, Cotecchia S (2003) The adaptor
complex 2 directly interacts with the alpha 1b-adrenergic receptor and
plays a role in receptor endocytosis. J Biol Chem 278:19331–19340.
Dixon RM,Mellor JR, Hanley JG (2009) PICK1-mediated glutamate recep-
tor subunit 2 (GluR2) trafficking contributes to cell death in oxygen/
glucose-deprived hippocampal neurons. J Biol Chem 284:14230–14235.
Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev
Biochem 78:857–902.
Dumoulin A, Rostaing P, Bedet C, Le´vi S, Isambert MF, Henry JP, Triller A,
Gasnier B (1999) Presence of the vesicular inhibitory amino acid trans-
porter in GABAergic and glycinergic synaptic terminal boutons. J Cell Sci
112:811–823.
Goodkin HP, Yeh JL, Kapur J (2005) Status epilepticus increases the intra-
cellular accumulation of GABAA receptors. J Neurosci 25:5511–5520.
Goto H, Terunuma M, Kanematsu T, Misumi Y, Moss SJ, Hirata M (2005)
Direct interaction of N-ethylmaleimide-sensitive factor with GABA(A)
receptor beta subunits. Mol Cell Neurosci 30:197–206.
Groc L, Choquet D (2006) AMPA and NMDA glutamate receptor traffick-
ing: multiple roads for reaching and leaving the synapse. Cell Tissue Res
326:423–438.
Hanley JG, Henley JM (2005) PICK1 is a calcium-sensor for NMDA-
induced AMPA receptor trafficking. EMBO J 24:3266–3278.
Haucke V, Wenk MR, Chapman ER, Farsad K, De Camilli P (2000) Dual
interaction of synaptotagmin with mu2- and alpha-adaptin facilitates
clathrin-coated pit nucleation. EMBO J 19:6011–6019.
Herring D, Huang R, Singh M, Robinson LC, Dillon GH, Leidenheimer NJ
(2003) Constitutive GABAA receptor endocytosis is dynamin-mediated
and dependent on a dileucine AP2 adaptin-binding motif within the beta
2 subunit of the receptor. J Biol Chem 278:24046–24052.
Jacob TC, Wan Q, Vithlani M, Saliba RS, Succol F, Pangalos MN, Moss SJ
(2009) GABA(A) receptor membrane trafficking regulates spine matu-
rity. Proc Natl Acad Sci U S A 106:12500–12505.
Jovanovic JN, Thomas P, Kittler JT, Smart TG, Moss SJ (2004) Brain-
derived neurotrophic factor modulates fast synaptic inhibition by regu-
lating GABAA receptor phosphorylation, activity, and cell-surface
stability. J Neurosci 24:522–530.
Kastning K, Kukhtina V, Kittler JT, Chen G, Pechstein A, Enders S, Lee SH,
Sheng M, Yan Z, Haucke V (2007) Molecular determinants for the in-
teraction between AMPA receptors and the clathrin adaptor complex
AP-2. Proc Natl Acad Sci U S A 104:2991–2996.
Kelley MH, Taguchi N, Ardeshiri A, Kuroiwa M, Hurn PD, Traystman RJ,
Herson PS (2008) Ischemic insult to cerebellar Purkinje cells causes di-
minished GABAA receptor function and allopregnanolone neuroprotec-
tion is associated with GABAA receptor stabilization. J Neurochem
107:668–678.
Kittler JT, Delmas P, Jovanovic JN, Brown DA, Smart TG, Moss SJ (2000)
Smith et al. • GABAA Receptor3-Subunit Internalization J. Neurosci., February 15, 2012 • 32(7):2485–2498 • 2497
Constitutive endocytosis of GABAA receptors by an association with the
adaptin AP2 complex modulates inhibitory synaptic currents in hip-
pocampal neurons. J Neurosci 20:7972–7977.
Kittler JT, Thomas P, Tretter V, Bogdanov YD, Haucke V, Smart TG,Moss SJ
(2004) Huntingtin-associated protein 1 regulates inhibitory synaptic
transmission by modulating gamma-aminobutyric acid type A receptor
membrane trafficking. Proc Natl Acad Sci U S A 101:12736–12741.
Kittler JT, Chen G, Honing S, Bogdanov Y, McAinsh K, Arancibia-Carcamo
IL, Jovanovic JN, Pangalos MN, Haucke V, Yan Z, Moss SJ (2005)
Phospho-dependent binding of the clathrin AP2 adaptor complex to
GABAA receptors regulates the efficacy of inhibitory synaptic transmis-
sion. Proc Natl Acad Sci U S A 102:14871–14876.
Kittler JT, Chen G, Kukhtina V, Vahedi-Faridi A, Gu Z, Tretter V, Smith KR,
McAinshK,Arancibia-Carcamo IL, SaengerW,HauckeV, YanZ,Moss SJ
(2008) Regulation of synaptic inhibition by phospho-dependent binding
of the AP2 complex to a YECL motif in the GABAA receptor gamma2
subunit. Proc Natl Acad Sci U S A 105:3616–3621.
Kurotani T, Yamada K, Yoshimura Y, Crair MC, Komatsu Y (2008) State-
dependent bidirectionalmodification of somatic inhibition in neocortical
pyramidal cells. Neuron 57:905–916.
Laurie DJ, Wisden W, Seeburg PH (1992) The distribution of thirteen
GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and
postnatal development. J Neurosci 12:4151–4172.
Lee SH, Liu L, Wang YT, Sheng M (2002) Clathrin adaptor AP2 and NSF
interact with overlapping sites of GluR2 and play distinct roles in AMPA
receptor trafficking and hippocampal LTD. Neuron 36:661–674.
Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:
1431–1568.
Liu B, Li L, ZhangQ,ChangN,WangD, ShanY, Li L,WangH, FengH, Zhang
L, Brann DW,WanQ (2010) Preservation of GABAA receptor function
by PTEN inhibition protects against neuronal death in ischemic stroke.
Stroke 41:1018–1026.
Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and op-
portunities in stroke. Nat Rev Neurosci 4:399–415.
Macaskill AF, Rinholm JE, Twelvetrees AE, Arancibia-Carcamo IL, Muir J,
Fransson A, Aspenstrom P, Attwell D, Kittler JT (2009) Miro1 is a cal-
cium sensor for glutamate receptor-dependent localization of mitochon-
dria at synapses. Neuron 61:541–555.
Martens H,WestonMC, Boulland JL, GrønborgM, Grosche J, Kacza J, Hoff-
mann A,MatteoliM, Takamori S, Harkany T, Chaudhry FA, Rosenmund
C, Erck C, Jahn R, Ha¨rtig W (2008) Unique luminal localization of
VGAT-C terminus allows for selective labeling of active cortical GABAe-
rgic synapses. J Neurosci 28:13125–13131.
Mielke JG, Wang YT (2005) Insulin exerts neuroprotection by counteract-
ing the decrease in cell-surface GABA receptors following oxygen-glucose
deprivation in cultured cortical neurons. J Neurochem 92:103–113.
Morrell CN, Matsushita K, Lowenstein CJ (2005) A novel inhibitor of
N-ethylmaleimide-sensitive factor decreases leukocyte trafficking and
peritonitis. J Pharmacol Exp Ther 314:155–161.
Muir J, Arancibia-Carcamo IL, MacAskill AF, Smith KR, Griffin LD, Kittler
JT (2010) NMDA receptors regulate GABAA receptor lateral mobility
and clustering at inhibitory synapses through serine 327 on the gamma2
subunit. Proc Natl Acad Sci U S A 107:16679–16684.
Nabi IR, Le PU (2003) Caveolae/raft-dependent endocytosis. J Cell Biol
161:673–677.
Naylor DE, Liu H, Wasterlain CG (2005) Trafficking of GABAA receptors,
loss of inhibition, and a mechanism for pharmacoresistance in status
epilepticus. J Neurosci 25:7724–7733.
Owen DJ, Evans PR (1998) A structural explanation for the recognition of
tyrosine-based endocytotic signals. Science 282:1327–1332.
Petrini EM, Lu J, Cognet L, Lounis B, Ehlers MD, Choquet D (2009) Endo-
cytic trafficking and recycling maintain a pool of mobile surface AMPA
receptors required for synaptic potentiation. Neuron 63:92–105.
Rosenmund C, Stevens CF (1996) Definition of the readily releasable pool
of vesicles at hippocampal synapses. Neuron 16:1197–1207.
Schwartz-Bloom RD, Sah R (2001) gamma-Aminobutyric acid(A) neu-
rotransmission and cerebral ischemia. J Neurochem 77:353–371.
Scott DB,Michailidis I, Mu Y, Logothetis D, Ehlers MD (2004) Endocytosis
and degradative sorting of NMDA receptors by conserved membrane-
proximal signals. J Neurosci 24:7096–7109.
Smith KR, Kittler JT (2010) The cell biology of synaptic inhibition in health
and disease. Curr Opin Neurobiol 20:550–556.
Smith KR, McAinsh K, Chen G, Arancibia-Carcamo IL, Haucke V, Yan Z,
Moss SJ, Kittler JT (2008) Regulation of inhibitory synaptic transmis-
sion by a conserved atypical interaction of GABA(A) receptor beta- and
gamma-subunits with the clathrin AP2 adaptor. Neuropharmacology
55:844–850.
Smith KR, Oliver PL, Lumb MJ, Arancibia-Carcamo IL, Revilla-Sanchez R,
Brandon NJ, Moss SJ, Kittler JT (2010) Identification and characterisa-
tion of a Maf1/Macoco protein complex that interacts with GABA(A)
receptors in neurons. Mol Cell Neurosci 44:330–341.
Tan HO, Reid CA, Single FN, Davies PJ, Chiu C, Murphy S, Clarke AL,
Dibbens L, Krestel H, Mulley JC, Jones MV, Seeburg PH, Sakmann B,
Berkovic SF, Sprengel R, Petrou S (2007) Reduced cortical inhibition in
amousemodel of familial childhood absence epilepsy. Proc Natl Acad Sci
U S A 104:17536–17541.
Terunuma M, Xu J, Vithlani M, Sieghart W, Kittler J, Pangalos M, Haydon
PG, Coulter DA, Moss SJ (2008) Deficits in phosphorylation of GABAA
receptors by intimately associated protein kinase C activity underlie com-
promised synaptic inhibition during status epilepticus. J Neurosci 28:
376–384.
The´venaz P, Ruttimann UE, Unser M (1998) A pyramid approach to sub-
pixel registration based on intensity. IEEE Trans Image Process 7:27–41.
Tretter V, Revilla-Sanchez R, Houston C, Terunuma M, Havekes R, Florian
C, Jurd R, Vithlani M, Michels G, Couve A, Sieghart W, Brandon N, Abel
T, Smart TG, Moss SJ (2009) Deficits in spatial memory correlate with
modified {gamma}-aminobutyric acid type A receptor tyrosine phos-
phorylation in the hippocampus. Proc Natl Acad Sci U S A 106:
20039–20044.
Triller A, Choquet D (2008) New concepts in synaptic biology derived from
single-molecule imaging. Neuron 59:359–374.
Twelvetrees AE, Yuen EY, Arancibia-Carcamo IL, MacAskill AF, Rostaing P,
Lumb MJ, Humbert S, Triller A, Saudou F, Yan Z, Kittler JT (2010)
Delivery of GABA(A)Rs to synapses is mediated by HAP1-KIF5 and dis-
rupted by mutant huntingtin. Neuron 65:53–65.
Vonderheit A, Helenius A (2005) Rab7 associates with early endosomes to
mediate sorting and transport of Semliki forest virus to late endosomes.
PLoS Biol 3:e233.
WisdenW, Laurie DJ,Monyer H, Seeburg PH (1992) The distribution of 13
GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, di-
encephalon, mesencephalon. J Neurosci 12:1040–1062.
Zhan RZ, Nadler JV, Schwartz-Bloom RD (2006) Depressed responses to
applied and synaptically-released GABA in CA1 pyramidal cells, but not
in CA1 interneurons, after transient forebrain ischemia. J Cereb Blood
Flow Metab 26:112–124.
2498 • J. Neurosci., February 15, 2012 • 32(7):2485–2498 Smith et al. • GABAA Receptor3-Subunit Internalization
